Publications
Export 34 results:
Filters: Author is Martin Lévesque [Clear All Filters]
“Millimetric scale two-photon Bessel-Gauss beam light sheet microscopy with three-axis isotropic resolution using an axicon lens.”, Neurophotonics, vol. 10, no. 3, p. 035002, 2023.
“The small GTPase Rit2 modulates LRRK2 kinase activity, is required for lysosomal function and protects against alpha-synuclein neuropathology.”, NPJ Parkinsons Dis, vol. 9, no. 1, p. 44, 2023.
“A light-inducible protein clustering system for in vivo analysis of α-synuclein aggregation in Parkinson disease.”, PLoS Biol, vol. 20, no. 3, p. e3001578, 2022.
, “Treating Parkinson's Disease with Antibodies: Previous Studies and Future Directions.”, J Parkinsons Dis, vol. 11, no. 1, pp. 71-92, 2021.
, “Opposite Control of Excitatory and Inhibitory Synapse Formation by Slitrk2 and Slitrk5 on Dopamine Neurons Modulates Hyperactivity Behavior.”, Cell Rep, vol. 30, no. 7, pp. 2374-2386.e5, 2020.
, “The Quebec Parkinson Network: A Researcher-Patient Matching Platform and Multimodal Biorepository.”, J Parkinsons Dis, vol. 10, no. 1, pp. 301-313, 2020.
, “Neuroprotective benefits of grape seed and skin extract in a mouse model of Parkinson's disease.”, Nutr Neurosci, pp. 1-15, 2019.
, “MT3-MMP Promotes Excitatory Synapse Formation by Promoting Nogo-66 Receptor Ectodomain Shedding.”, J Neurosci, vol. 38, no. 3, pp. 518-529, 2018.
, “Survival of a Novel Subset of Midbrain Dopaminergic Neurons Projecting to the Lateral Septum Is Dependent on NeuroD Proteins.”, J Neurosci, vol. 37, no. 9, pp. 2305-2316, 2017.
, “Transcriptional repression of Plxnc1 by Lmx1a and Lmx1b directs topographic dopaminergic circuit formation.”, Nat Commun, vol. 8, no. 1, p. 933, 2017.
, “Lmx1a and Lmx1b regulate mitochondrial functions and survival of adult midbrain dopaminergic neurons.”, Proc Natl Acad Sci U S A, vol. 113, no. 30, pp. E4387-96, 2016.
, “Mesocortical Dopamine Phenotypes in Mice Lacking the Sonic Hedgehog Receptor Cdon.”, eNeuro, vol. 3, no. 3, 2016.
, “Normal Molecular Specification and Neurodegenerative Disease-Like Death of Spinal Neurons Lacking the SNARE-Associated Synaptic Protein Munc18-1.”, J Neurosci, vol. 36, no. 2, pp. 561-76, 2016.
, “Cell fate determination, neuronal maintenance and disease state: The emerging role of transcription factors Lmx1a and Lmx1b.”, FEBS Lett, vol. 589, no. 24 Pt A, pp. 3727-38, 2015.
, “Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.”, Neurobiol Dis, vol. 82, pp. 430-444, 2015.
, “Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons.”, Curr Biol, vol. 25, no. 18, pp. 2349-60, 2015.
, “The morphological and molecular changes of brain cells exposed to direct current electric field stimulation.”, Int J Neuropsychopharmacol, vol. 18, no. 5, 2014.
, “The Shh receptor Boc promotes progression of early medulloblastoma to advanced tumors.”, Dev Cell, vol. 31, no. 1, pp. 34-47, 2014.
, “Boc and Gas1 each form distinct Shh receptor complexes with Ptch1 and are required for Shh-mediated cell proliferation.”, Dev Cell, vol. 20, no. 6, pp. 788-801, 2011.
, “Lmx1a and lmx1b function cooperatively to regulate proliferation, specification, and differentiation of midbrain dopaminergic progenitors.”, J Neurosci, vol. 31, no. 35, pp. 12413-25, 2011.
, “L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.”, J Chem Neuroanat, vol. 35, no. 1, pp. 77-84, 2008.
, “The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.”, Brain, vol. 130, no. Pt 1, pp. 222-32, 2007.
, “Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra.”, Neurosci Res, vol. 57, no. 3, pp. 362-71, 2007.
